Investors in Health

The primary mission of Invest.BW is to sustainably support prosperity and entrepreneurial dynamism in Walloon Brabant. Invest.BW intervenes financially over the time horizon agreed together alongside entrepreneurs who will positively impact our province and in line with the economic, environmental and societal development desired for Wallonia. It aims for a fair return commensurate with the risk taken.

Cascara is committed to building successful businesses through effective partnerships with outstanding entrepreneurs. They invest only in areas where they have domain expertise. They prefer to act as lead investor and take a board seat, providing strategic, operational, and financial advice. They bring insights and advantages from their large network of relationships in the industry. They are long-term investors and believe in adding value by working together with portfolio company management teams to help build market-leading companies.

Sopartec's mission, within the Louvain Technology Transfer Office (LTTO), is to transfer the results of research carried out by UCLouvain, the Cliniques universitaires St-Luc (CUSL), the CHU UCL Namur and the Institute de Duve (ICP) to the public/market by creating spin-offs and negotiating licence agreements. Sopartec is working with the VIVES Investment Funds (VIVES). The VIVES Funds are technology multi-sectorial funds that invest in UCLouvain spin-offs and startups in both Belgium and neighboring countries.

Lumiares proactively pursues the most promising digital health opportunities which it funds and supports from the incubation phase onwards. In addition to its internal team, it leverages a strong network of external clinical, technological and business experts to validate innovative digital health solutions and accelerate their time-to-market. Lumiares helps them develop a strong value proposition and scalable business model with clear benefits to patients, care givers and payers.

Cleverton invests in tech companies with disruptive potential. They focus on FinTech, InsurTech, HealthTech, and FoodTech. Join them in investing in the future. Together, they aim to drive innovation and create lasting impact.

Gimv is a European investment company listed on Euronext Brussels. As a recognized market leader, they partner with entrepreneurial and innovative companies in five forward-looking investment areas. They currently manage a portfolio of around 60 companies with a combined turnover of EUR 4.0 billion and more than 20,000 employees.

FlyCap is a Latvian venture capital fund that provides growth capital for small- and medium-sized enterprises.

BAF is a venture capital firm which invests in startups, early stage companies and SMEs in Baltic region. Business Angel Fund's investment size varies between 50k and 600k EUR. BAF invests along with Business Angels same conditions .

VC investor, pre-seed or seed, in Europe, impact bias, sweet spot EUR 100k. Investing in early stage startups and other alternative assets with a long-term investment horizon and bias towards impact investing.

At Verlinvest they are passionate about growing brands that shine a light on issues and drive better consumption habits. They use patient, permanent capital to build businesses for the long-term. They invest across three core strategies: Growth, Platform, and Venture (via V3 Ventures).

Novalis Biotech is an early-stage venture capital investor in life sciences. They welcome innovative concepts in healthcare and aim to support their development from the state of incorporation. Their investment focus is on “enabling technologies” in life sciences. They strongly believe in capital-light platform technology and close interaction with customers early in the life of the company. Focus areas include innovative research and manufacturing tools, bioinformatics, genomics, diagnostics, and digital health.

White Fund is a Belgian medtech venture capitalist fund. Founded in 2019, it aims to support the pre-market stages of projects and the launch of sales, with an exit target of 5-8 years. The fund has a size of EUR 38 million, in order to finance about 10 projects. Investors in the fund include Business Angels, SFPI-FPIM, Invest For Jobs, Finance&Invest.Brussels, Noshaq, Ogeo Fund, Solidaris and CHU de Liège.